Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117041) titled 'Study on the Role and Mechanism of Folic Acid in Cognitive Dysfunction of Patients with Schizophrenia with Low Folic Acid Levels' on Jan. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University
Condition:
schizophrenia
Intervention:
Research Group:Atypical antipsychotic drugs + oral folic acid, 15mg per day, for 24 weeks of treatment
control group:Monotherapy with Atypical antipsychotic drugs for 12 weeks
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-19
Target Sample Size: Research Group:...